About this Journal Submit a Manuscript Table of Contents
ISRN Immunology
Volume 2012 (2012), Article ID 817478, 6 pages
http://dx.doi.org/10.5402/2012/817478
Review Article

Overview of Achievements and Challenges of the Fight against AIDS in China

Shanghai Municipal Center for Disease Control and Prevention, 1380 Zhong Shan Xi Road, Shanghai 200336, China

Received 18 January 2012; Accepted 7 March 2012

Academic Editors: I. Mezzaroma, A. Taylor-Robinson, and A. Vyakarnam

Copyright © 2012 Laiyi Kang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Y. Kang, “Threatened by the high-risk factors,” AIDS Analysis, vol. 1, no. 1, article 16, 1995.
  2. Ministry of Health, People’s Republic of China Joint United Nations Programme on HIV/AIDS and World Health Organization, “Estimates for the HIV/AIDS epidemic in China. National Center for AIDS/STD Control and Prevention,” CDC, Beijing, China, May 2010.
  3. CDC and Ministry of Health, People’s Republic of China Joint United Nations Programme on HIV/AIDS and World Health Organization, “Estimates for the HIV/AIDS epidemic in China.,” National Center for AIDS/STD Control and Prevention, CDC, Zhejiang, China, 2011, http://www.chinaids.org.cn/n1971/n2151/777994.html.
  4. L. Y. Kang and X. Z. Pan, Prevention and Treatment of AIDS, Fu Dan University Press, 2008.
  5. B. A. Kohler, E. Ward, B. J. McCarthy et al., “Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system,” Journal of the National Cancer Institute, vol. 103, no. 9, pp. 714–736, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. State Council, Regulation on Prevention and Control of AIDS, China Legal System Press, 2006.
  7. The 93rd Order from the President of the People’s Republic of China, “Law of Blood Donation of the People’s Republic of China,” in Proceedings of the 8th National People Representative Congress, China Legal System Press, December 1997.
  8. Ministry of Health, People’s Republic of China, Regulation on National Working Management of AIDS Testing, China Legal System Press, 2006.
  9. L. Y. Kang, “Objectives and significance of stipulation for “Regulation on National Management of HIV Laboratory Testing”,” Chinese Journal of Laboratory Medicine, vol. 31, no. 10, pp. 1091–1094, 2008.
  10. Y. M. Shao, L. Y. Kang, N. Wang, et al., “Health Industry Criteria of the People’s Republic of China: Diagnosis Criteria for AIDS and HIV infection,” The Ministry of Health, the People’s Republic of China, 2007.
  11. The State Council, “Decision on Revising “Implementation Regulations on the People’s Republic of China Law of Border Health Quarantine”,” April 2010, http://www.chinaaid.org/.
  12. M. Jia, H. Luo, Y. Ma et al., “The HIV epidemic in Yunnan province, China, 1989–2007,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, supplement, pp. S34–S40, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Xiao, J. Sun, C. Li et al., “Prevalence and correlates of HIV and syphilis infections among men who have sex with men in seven Provinces in China with historically low HIV prevalence,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, supplement, pp. S66–S73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Li, Z. Wang, D. Sun et al., “HIV among plasma donors and other high-risk groups in Henan, China,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, supplement, pp. S41–S47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Li, R. Detels, P. Lin et al., “Prevalence of HIV and STIs and associated risk factors among female sex workers in guangdong Province, China,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, supplement, pp. S48–S53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Wang, W. Liu, L. Wang, Y. Wang, and Z. Wu, “HIV prevalence among pulmonary tuberculosis patients in Guangxi, China,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, pp. S61–S65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Remis, L. Y. Kang, Q. C. Pan, et al., “Prevalence of HIV infection and STI among female entertainment workers (FEWs) in Shanghai, China,” in Proceedings of the 18th International AIDS Conference (AIDS '10), Vienna, Austria, July 2010.
  18. H. Zou, Z. Wu, J. Yu et al., “Sexual risk behaviors and HIV infection among men who have sex with men who use the internet in Beijing and Urumqi, China,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, supplement, pp. S81–S87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Feng, Z. Wu, and R. Detels, “Evolution of men who have sex with men community and experienced stigma among men who have sex with men in Chengdu, China,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, supplement, pp. S98–S103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Ministry of Health of the People’s Republic of China, “UNGASS Country Progress Report, China, 2010,” Printed by the State Council AIDS Working Committee Office, April 2010.
  21. State Council AIDS Working Committee Office and UN theme Group on AIDS in China, “A Joint Assessment of HIV/AIDS Prevention, Treatment and Care in China,” State Council AIDS Working Committee Office, December 2007.
  22. Ministry of Health, People’s Republic of China, Joint United Nations Programme on HIV/AIDS, World Health Organization, “Update on the HIV/AIDS Epidemic and Response in China,” National Center for AIDS/STD Prevention and Control, China CDC, Beijing, China, January 2006.
  23. F. J. Zhang, “Progress on Anti-retroviral therapy in China,” Speech at National Free Charge of ART and HIV drug resistance in clinic, Beijing, China, December 2011.
  24. W. S. Guo, Q. H. Hu, M. Zhang, W. G. Cui, and H. Li, “Survey of anti-HIV treatment for HIV infections and development of drug resistance in Henan province,” Chinese Journal of AIDS & STD, vol. 12, no. 4, pp. 304–306, 2006.
  25. Y.-M. Shao and L.-Y. Kang, “Some suggestions on Strengthening the clinical work of AIDS in China,” Journal for China AIDS/STD Prevention and Control, vol. 6, no. 6, p. 382, 2000.
  26. L. Y. Kang and X. Z. Pan, “Development and application of antiretroviral therapy for Required Immunodeficiency Syndrome,” Chinese Journal of Infectious Diseases, vol. 20, pp. 133–136, 2002.
  27. F. J. Zhang, J. Pan, and L. Yu, “Current progress of China’s free ART program,” Cell Research, vol. 15, pp. 877–882, 2005.
  28. The Editor Group, National Textbook on Antiretroviral Drug Therapy in Free of Charge, People’s Health Publishing, Beijing, China, 2nd edition, 2008.
  29. Y. Shao, “AIDS epidemic at age 25 and control efforts in China,” Retrovirology, vol. 3, p. 87, 2006.
  30. X. Han, D. Dai, B. Zhao et al., “Genetic and epidemiologic characterization of HIV-1 infection in liaoning province, China,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, supplement, pp. S27–S33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. R. Yi, H. Y. Loo, and L. S. Bai, “Characteristic Study on epidemic HIV-1 strain of CRF01_AE subtype in Beijing,” Chinese Journal of Epidemiology, vol. 31, no. 11, pp. 1231–1234, 2010.
  32. L. Li, S. Liang, L. Chen et al., “Genetic characterization of 13 subtype CRF01-AE near full-length genomes in Guangxi, China,” AIDS Research and Human Retroviruses, vol. 26, no. 6, pp. 699–704, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Deng, P. Fu, L. Bao et al., “Molecular epidemiological tracing of HIV-1 outbreaks in Hainan island of southern China,” AIDS, vol. 23, no. 8, pp. 977–985, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Zhong, Q. Pan, Z. Ning et al., “Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai,” AIDS Research and Human Retroviruses, vol. 23, no. 7, pp. 847–856, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Guo, D. Guo, J. F. Wei et al., “First detection of a novel HIV type 1 CRF01-AE/07-BC recombinant among an epidemiologically linked cohort of IDUs in jiangsu, China,” AIDS Research and Human Retroviruses, vol. 25, no. 4, pp. 463–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Zhong, Q. Pan, Z. Ning et al., “Genetic diversity and drug resistance of human immunodeficiency virus type 1 (HIV-1) strains circulating in Shanghai,” AIDS Research and Human Retroviruses, vol. 23, no. 7, pp. 847–856, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. P. Zhong, L. Kang, Q. Pan et al., “Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P. R. China,” Journal of Acquired Immune Deficiency Syndromes, vol. 34, no. 1, pp. 91–101, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. J. R. Ye and Y. Zeng, “Progress of study on HIV subtype in China, 2000–2010,” unpublished.
  39. Y. M. Shao, J. Y. Li, L.Y. Kang, H. Shang, P. Zhong, and H. Xing, Book on the Strategy and Methodology for HIV Drug Resistance Surveillance and Detection, People’s Medical Publishing House, 2010.
  40. L. Liao, H. Xing, H. Shang et al., “The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, supplement, pp. S10–S14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Y. Choi, E. J. Kim, Y. K. Park, J. S. Lee, and S. S. Kim, “National survey for drug-resistant variants in newly diagnosed antiretroviral drug-naive patients with HIV/AIDS in South Korea: 1999–2005,” Journal of Acquired Immune Deficiency Syndromes, vol. 49, no. 3, pp. 237–242, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. N. Vidal, C. Mulanga, S. E. Bazepeo et al., “HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC),” AIDS Research and Human Retroviruses, vol. 22, no. 2, pp. 202–206, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. Chinese HIV Drug resistance Research Group, “Public Health Surveillance on HIV-1 drug resistance from 2004 to 2010 in China,” In press.
  44. Y. Han, J. Q. Kuang, T. S. Li et al., “Surveillance on primary genotyping drug resistance among 237 naïve-patients with HIV/AIDS and analysis of HIV subtypes in China,” Chinese Journal of Laboratory Medicine, vol. 31, no. 10, pp. 1095–1100, 2008.
  45. L. G. Feng, H. J. M. Wang, M. Han, X. B. Dian, and Y. Jiang, “Surveillance on HIV drug resistance for recently acute infection among MSM who have sex with men in Zhongqing,” Chinese Journal of Epidemiology, vol. 29, no. 5, pp. 455–458, 2008.
  46. H. Tan, F. G. Zhan, W. P. Chen, D. H. Peng, Y. Dai, and X. G. Zhu, “Analysis of drug resistance surveillance among Anti-HIV treatment individuals in Hubei province,” Public Health and Preventive Medicine, vol. 18, no. 5, pp. 26–28, 2007.
  47. X. B. Zhu, J. M. He, G. Q. Zhang, X. Z. Li, J. Y. Peng, and X. Chen, “Analysis of drug resistance among patients after ART in Hunan province,” Chinese Journal of AIDS & STD, vol. 9, no. 5, pp. 305–309, 2010.
  48. China CDC, Working Plan for HIV Drug Resistance in 2010, Office of China CDC, 2010.
  49. L. Y. Kang, “Development and application of HIV testing technologies for HIV/AIDS highly active anti-retroviral therapy in China,” Chinese Journal of Laboratory Medicine, vol. 32, no. 4, pp. 365–368, 2009.
  50. The Ministry of Science and Technology, People’s Republic of China, “National “Eleventh Five-Years” Science and Technology Development Plan—Prevention and Control of AIDS, Viral Hepatitis, etc.,” March 2011, http://most.gov.cn/.
  51. The State Council, “Information of Further Strengthening Work on Prevention and Control of AIDS,” February 2011, http://www.chinaaids.org/.
  52. The Office of Ministry of Health, “Information on Carrying out Protocol of the Work on Prevention of AIDS, Syphilis and HBV Maternal Infant Transmission,” February 2011, http://www.chinaaids.org/.
  53. Z. Wu and Y. Wang, “Introduction: China meets new AIDS challenges,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, supplement, pp. S1–S3, 2010. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Y. Kang, “It's necessary to educate and promote of condom use as an important intervention to interrupt of HIV/STD transmission,” China Journal of Prevention and Control of STD/AIDS, vol. 2, no. 6, p. 282, 1996.
  55. K. Lai-Yi, F. Hui, J. Zhi-Chen, et al., “A feasibility study on condom use in a hotel,” Chinese Journal of Epidemiology, vol. 3, no. 13, p. 100, 1995.
  56. Y. C. Wang, C. D. Zhang, S. B. Xu, H. Z. Yi, et al., HIV Laboratory Testing Technique and Quality Assurance, Science Publishing, Beijing, China, 2009.
  57. Y. Jiang, N. Wang, W. G. Xing, Y. Xiao, J. Yao, P. L. Pan, et al., Book on Development of a Network of AIDS Laboratory for 20 Years in China, Beijing Science and Technology Publishing, Beijing, China, 2009.
  58. Z. Zhou, K. Meyers, X. Li et al., “Prevention of mother-to-child transmission of HIV-1 using highly active antiretroviral therapy in rural Yunnan, China,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, supplement, pp. S15–S22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Zhang, J. E. Haberer, Y. Wang et al., “The Chinese free antiretroviral treatment program: challenges and responses,” AIDS, vol. 21, no. 8, supplement, pp. S143–S148, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. L. Xiao, Z. Wu, W. Luo, and X. Wei, “Quality of life of outpatients in methadone maintenance treatment clinics,” Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 1, supplement, pp. S116–S120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. The Office of Ministry of Health, “Information on Carrying out Protocol of the Work on Prevention of AIDS, Syphilis and HBV Maternal Infant Transmission,” February 2011, http://www.chinaaids.org/.
  62. Ministry of Health, “Carrying Out Regulations on Management Rules in Public Places (The No. 80 Order from the Ministry of Health),” March 2011, http://www.chinaaids.org/.